Fortress Biotech, Inc. (FBIO)
2.03
-0.04
(-1.93%)
USD |
NASDAQ |
Oct 02, 16:00
2.035
0.00 (0.00%)
Pre-Market: 20:00
Fortress Biotech Price to Book Value : 0.412 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.412 |
| October 01, 2026 | 0.4201 |
| September 30, 2026 | 0.4343 |
| September 29, 2026 | 0.4465 |
| September 28, 2026 | 0.4404 |
| September 25, 2026 | 0.4627 |
| September 24, 2026 | 0.4627 |
| September 23, 2026 | 0.4749 |
| September 22, 2026 | 0.4972 |
| September 21, 2026 | 0.4891 |
| September 18, 2026 | 0.5094 |
| September 17, 2026 | 0.5094 |
| September 16, 2026 | 0.4992 |
| September 15, 2026 | 0.5053 |
| September 14, 2026 | 0.5135 |
| September 11, 2026 | 0.5114 |
| September 10, 2026 | 0.5216 |
| September 09, 2026 | 0.5337 |
| September 08, 2026 | 0.55 |
| September 04, 2026 | 0.552 |
| September 03, 2026 | 0.55 |
| September 02, 2026 | 0.554 |
| September 01, 2026 | 0.5439 |
| August 31, 2026 | 0.5551 |
| August 28, 2026 | 0.5622 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.5682 |
| August 26, 2026 | 0.5703 |
| August 25, 2026 | 0.5743 |
| August 24, 2026 | 0.5946 |
| August 21, 2026 | 0.5825 |
| August 20, 2026 | 0.5622 |
| August 19, 2026 | 0.5784 |
| August 18, 2026 | 0.5906 |
| August 17, 2026 | 0.5723 |
| August 14, 2026 | 0.5946 |
| August 13, 2026 | 0.6048 |
| August 12, 2026 | 0.5581 |
| August 11, 2026 | 0.5297 |
| August 10, 2026 | 0.5581 |
| August 07, 2026 | 0.5419 |
| August 06, 2026 | 0.5622 |
| August 05, 2026 | 0.5662 |
| August 04, 2026 | 0.552 |
| August 03, 2026 | 0.5601 |
| July 31, 2026 | 0.6352 |
| July 30, 2026 | 0.6677 |
| July 29, 2026 | 0.6799 |
| July 28, 2026 | 0.688 |
| July 27, 2026 | 0.6636 |
| July 24, 2026 | 0.6778 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 21.85 |
| Kura Oncology, Inc. | 19.56 |
| Spero Therapeutics, Inc. | 1.565 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
Price to Book Value Related Metrics
| PE Ratio | 0.7641 |
| PS Ratio | 0.9982 |
| Price to Free Cash Flow | 0.5682 |
| Price | 2.03 |
| Earnings Yield | 130.9% |
| Market Cap | 67.62M |
| Normalized PE Ratio | 0.829 |